Browsing by 저자 : Daniel Castellano
전체 결과 9건 중 1-9 번을 표시중입니다.
-
1
Article
Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial
Sumanta K Pal
;
Javier Puente
;
Daniel Y C Heng
;
et al
2022
-
2
Article
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)
Alexandra Drakaki
;
Thomas Powles
;
Aristotelis Bamias
;
et al
2023
-
3
Article
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
이재련
;
Andre P Fay
;
Andrea Necchi
;
et al
2020
-
4
Article
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
이재련
;
Christof Vulsteke
;
Chunzhang Wu
;
et al
2021
-
5
Article
Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy
Ronald de Wit
;
Thomas Powles
;
Daniel Castellano
;
et al
2022
-
6
Article
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study
Do-Youn Oh
;
Maria Alsina Maqueda
;
David I Quinn
;
et al
2023
-
7
Article
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
이재련
;
Boris Yakovlevich Alekseev
;
Charles Schloss
;
et al
2021
-
8
Article
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Joaquim Bellmunt
;
Ronald de Wit
;
Yves Fradet
;
et al
2022
-
9
Article
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
Talal El Zarif
;
Amin H Nassar
;
Gregory R Pond
;
et al
2023